Sequential therapy with activated prothrombin complex concentrate (FEIBA) and recombinant factor VIIa in a patient with severe haemophilia A, inhibitor presence and refractory bleeding
2008; Wiley; Volume: 14; Issue: 2 Linguagem: Inglês
10.1111/j.1365-2516.2007.01635.x
ISSN1365-2516
AutoresMarina Economou, Αikaterini Teli, Aikaterini Tzantzaroudi, Ioanna Tsatra, A. Zavitsanakis, M. Athanassiou‐Metaxa,
Tópico(s)Coagulation, Bradykinin, Polyphosphates, and Angioedema
ResumoHaemophiliaVolume 14, Issue 2 p. 390-391 Sequential therapy with activated prothrombin complex concentrate (FEIBA) and recombinant factor VIIa in a patient with severe haemophilia A, inhibitor presence and refractory bleeding M. ECONOMOU, M. ECONOMOU 1st Department of Pediatrics, Aristotle University of Thessaloniki, "Hippokration" General HospitalSearch for more papers by this authorA. TELI, A. TELI 1st Department of Pediatrics, Aristotle University of Thessaloniki, "Hippokration" General HospitalSearch for more papers by this authorA. TZANTZAROUDI, A. TZANTZAROUDI 1st Department of Pediatric Surgery, Aristotle University of Thessaloniki, "G. Gennimatas" General Hospital, Thessaloniki, GreeceSearch for more papers by this authorI. TSATRA, I. TSATRA 1st Department of Pediatrics, Aristotle University of Thessaloniki, "Hippokration" General HospitalSearch for more papers by this authorA. ZAVITSANAKIS, A. ZAVITSANAKIS 1st Department of Pediatric Surgery, Aristotle University of Thessaloniki, "G. Gennimatas" General Hospital, Thessaloniki, GreeceSearch for more papers by this authorM. ATHANASSIOU-METAXA, M. ATHANASSIOU-METAXA 1st Department of Pediatrics, Aristotle University of Thessaloniki, "Hippokration" General HospitalSearch for more papers by this author M. ECONOMOU, M. ECONOMOU 1st Department of Pediatrics, Aristotle University of Thessaloniki, "Hippokration" General HospitalSearch for more papers by this authorA. TELI, A. TELI 1st Department of Pediatrics, Aristotle University of Thessaloniki, "Hippokration" General HospitalSearch for more papers by this authorA. TZANTZAROUDI, A. TZANTZAROUDI 1st Department of Pediatric Surgery, Aristotle University of Thessaloniki, "G. Gennimatas" General Hospital, Thessaloniki, GreeceSearch for more papers by this authorI. TSATRA, I. TSATRA 1st Department of Pediatrics, Aristotle University of Thessaloniki, "Hippokration" General HospitalSearch for more papers by this authorA. ZAVITSANAKIS, A. ZAVITSANAKIS 1st Department of Pediatric Surgery, Aristotle University of Thessaloniki, "G. Gennimatas" General Hospital, Thessaloniki, GreeceSearch for more papers by this authorM. ATHANASSIOU-METAXA, M. ATHANASSIOU-METAXA 1st Department of Pediatrics, Aristotle University of Thessaloniki, "Hippokration" General HospitalSearch for more papers by this author First published: 10 January 2008 https://doi.org/10.1111/j.1365-2516.2007.01635.xCitations: 13 Marina Economou, MD, PhD, 1st Department of Pediatrics, Aristotle University of Thessaloniki, "Hippokration" General Hospital, Thessaloniki, Th. Sofouli 64, 546 45, Greece.Tel./fax: ++30 31 857 111; e-mail: [email protected] Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. References 1 Mehta R, Parameswaran R, Shapiro D. An overview of the history, clinical practice concerns, comparative studies and strategies to optimize therapy of bypassing agents. Haemophilia 2006; 12(Suppl. 6): 54– 61. 2 Shapiro A. Inhibitor treatment: state of the art. Dis Mon 2003; 49: 22– 38. 3 Key N, Christie B, Henderson N, Nelsestuen G. Possible synergy between recombinant factor VIIa and prothrombin complex concentrated in hemophilia therapy. Thromb Haemost 2002; 88: 60– 5. 4 Schneiderman J, Nugent D, Young G. Sequential therapy with activated prothrombin complex concentrate and recombinant factor VIIa in patients with severe haemophilia and inhibitors. Haemophilia 2004; 10: 347– 51. 5 Rosenfeld S, Watkinson K, Thompson B, MacFarlane D, Lentz S. Pulmonary embolism after sequential use of recombinant factor VIIa and activated prothrombin complex concentrate in a factor VIII inhibitor patient. Thromb Haemost 2002; 87: 925– 6. Citing Literature Volume14, Issue2March 2008Pages 390-391 ReferencesRelatedInformation
Referência(s)